#news #biotech GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19 .GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
badams
Wed, 02/17/2021 – 04:03

from FierceBiotech: Biotech https://ift.tt/3s2FPTG